Nephros (NEPH) Cash & Equivalents Growth (1y) (2011 - 2026)
Nephros (NEPH) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -19.91% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -3.67% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -3.76% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 21.48% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -14.50% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -18.09% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 19.45% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 27.52% |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | -7.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.43% |
| Mar 31, 2026 | -1.54% |
| Dec 31, 2025 | 43.62% |
| Sep 30, 2025 | 110.46% |
| Jun 30, 2025 | 64.74% |
| Mar 31, 2025 | 12.33% |
| Dec 31, 2024 | -12.70% |
| Sep 30, 2024 | -46.84% |
| Jun 30, 2024 | -24.14% |
| Mar 31, 2024 | -5.29% |
| Dec 31, 2023 | 18.52% |
| Sep 30, 2023 | 17.31% |
| Jun 30, 2023 | -2.85% |
| Mar 31, 2023 | -29.24% |
| Dec 31, 2022 | -47.88% |
| Sep 30, 2022 | -46.39% |
| Jun 30, 2022 | -49.52% |
| Mar 31, 2022 | -33.59% |
| Dec 31, 2021 | -15.47% |
| Sep 30, 2021 | 42.58% |